PL445405A1 - Nowa pochodna 1,3,5-triazyny i jej zastosowanie - Google Patents

Nowa pochodna 1,3,5-triazyny i jej zastosowanie

Info

Publication number
PL445405A1
PL445405A1 PL445405A PL44540523A PL445405A1 PL 445405 A1 PL445405 A1 PL 445405A1 PL 445405 A PL445405 A PL 445405A PL 44540523 A PL44540523 A PL 44540523A PL 445405 A1 PL445405 A1 PL 445405A1
Authority
PL
Poland
Prior art keywords
triazine
application
new derivative
new
derivative
Prior art date
Application number
PL445405A
Other languages
English (en)
Other versions
PL247599B1 (pl
Inventor
Damian Kułaga
Anna Karolina Drabczyk
Izabela SIEMIŃSKA
Original Assignee
Politechnika Krakowska im. Tadeusza Kościuszki
Uniwersytet Rolniczy im. Hugona Kołłątaja w Krakowie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Politechnika Krakowska im. Tadeusza Kościuszki, Uniwersytet Rolniczy im. Hugona Kołłątaja w Krakowie filed Critical Politechnika Krakowska im. Tadeusza Kościuszki
Priority to PL445405A priority Critical patent/PL247599B1/pl
Publication of PL445405A1 publication Critical patent/PL445405A1/pl
Publication of PL247599B1 publication Critical patent/PL247599B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Przedmiotem zgłoszenia jest nowa pochodna tryptamino-1,3,5-triazyny, którą stanowi chlorowodorek 6-(4-(benzo[d]izotiazo-3-ilo)piperaz-1-yno)-N2-fenyl-1,3,5-triazyno-2,4-diaminy o wzorze 1 do zastosowania w leczeniu nowotworu jelita grubego.
PL445405A 2023-06-29 2023-06-29 Nowa pochodna 1,3,5-triazyny i jej zastosowanie PL247599B1 (pl)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL445405A PL247599B1 (pl) 2023-06-29 2023-06-29 Nowa pochodna 1,3,5-triazyny i jej zastosowanie

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL445405A PL247599B1 (pl) 2023-06-29 2023-06-29 Nowa pochodna 1,3,5-triazyny i jej zastosowanie

Publications (2)

Publication Number Publication Date
PL445405A1 true PL445405A1 (pl) 2024-12-30
PL247599B1 PL247599B1 (pl) 2025-08-04

Family

ID=96584850

Family Applications (1)

Application Number Title Priority Date Filing Date
PL445405A PL247599B1 (pl) 2023-06-29 2023-06-29 Nowa pochodna 1,3,5-triazyny i jej zastosowanie

Country Status (1)

Country Link
PL (1) PL247599B1 (pl)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014025749A2 (en) * 2012-08-06 2014-02-13 Sirga Advanced Biopharma, Inc. Small molecule inhibitors of viral protein interactions with human t-rna
CN113004246B (zh) * 2021-02-22 2022-02-01 广西医科大学 1，3，5-三嗪-2-胺-4，6取代衍生物或其药学上可接受的盐和用途

Also Published As

Publication number Publication date
PL247599B1 (pl) 2025-08-04

Similar Documents

Publication Publication Date Title
NO20070453L (no) Kondenserte heterocykliske kinase inhibitorer
NZ580671A (en) Pyrimidine derivatives
GEAP202215535A (en) Compounds
NO20082089L (no) Fosfatidylinositol 3-kinaseinhibitorer og deres anvendelse
NO20060774L (no) Kinolin- og kinazolinderivater som har affinitet for 5HT1-typereseptorer
NZ594385A (en) Aminopyrimidines useful as kinase inhibitors
MX2008011123A (es) Benzotiazoles que tienen actividad de receptor h3 de histamina.
CY1117951T1 (el) Αναστολεiς κινασης υποκατεστημενης τριαζινης
BR0308243A (pt) Composto, formulação farmacêutica, e, métodos de tratar diabetes, doença de alzheimer, e de inibir gsk-3 em um mamìfero
BR0213899A (pt) Aminopirimidinas e aminopiridinas
NO20044475L (no) 2-(2,6-diklorfenyl)-diarulimidazoler
PA8595201A1 (es) Preparacion de quinazolinas substituidas
NO20060398L (no) Anvendelse av en kombinasjon av en epidermal vekstfaktor reseptor kinase inhibitor og cytotoksiske midler for behandling og hemming av kreft
MX2007004781A (es) Derivados de 3-arilamino piridina.
UY27742A1 (es) Derivados de quinazolina
DE60206911D1 (de) Imidazol-2-carbonsäureamid derivate als raf-kinase-inhibitoren
MA33721B1 (fr) Derives sulfonamides heterocycliques utilises comme inhibiteurs de mek
GEP20156224B (en) Therapeutic agent for mood disorders
ATE355265T1 (de) Biphenylcarboxamidderivate und ihre verwendung als p38 kinase inhibitoren
GEAP202315557A (en) Spirochromane derivatives
DE60108626D1 (de) Verwendung von 5-thio, sulfinyl- und sulfonylpyrazolo 3,4-b] pyridinen als cyclin-abhängige kinase-hemmer
PL445405A1 (pl) Nowa pochodna 1,3,5-triazyny i jej zastosowanie
MX2022012934A (es) Agente terapeutico para cancer de mama.
EA200900034A1 (ru) Применение ингибитора р38 киназы для лечения психиатрических расстройств
PL445400A1 (pl) Nowa pochodna 1,3,5-triazyny i jej zastosowanie